Botox has been FDA-approved for cosmetic use since 2002 and studied in tens of thousands of patients since, but the misconceptions haven’t faded with the data. We hear some version of the same handful of myths in nearly every consultation. HALO already covers how to make results last longer and how Botox compares to Dysport, Xeomin, and Letybo — this post takes on the myths themselves, checked against the actual clinical research rather than what shows up in comment sections.
Myth 1: “Botox Is a Dangerous Toxin”
It’s true that botulinum toxin is, chemically, a toxin — that’s where the name comes from. But the cosmetic dose is a tiny fraction of what would ever reach a harmful level, and it’s injected locally into a specific muscle rather than entering general circulation. A 2022 systematic review and meta-analysis in the Aesthetic Surgery Journal pooled 24 studies covering 4,268 cosmetic botulinum toxin A injection sessions — just over half using onabotulinumtoxinA, the Botox formulation — against 1,234 placebo-controlled injections. For onabotulinumtoxinA specifically, the complication rate was 16% and not statistically different from placebo (odds ratio 1.34), with the reviewers describing most complications as mild and transient. Remote, systemic-type reactions were rare across the pooled data, showing up in only 0.3% of injections.
Myth 2: “You’ll End Up Looking Frozen or Fake”
This myth usually comes from seeing overdone results, not typical ones. A 2023 post hoc analysis of two pivotal Phase 3 trials for onabotulinumtoxinA (Botox Cosmetic) — nearly 460 neurotoxin-naive patients treated for forehead and glabellar lines, published in the Journal of Cosmetic Dermatology — found that 90.5% of patients were satisfied their results looked natural at day 30, rising to 94.6% among younger (millennial) patients, with natural-look satisfaction holding above 80% through the full 12-month follow-up. Modern dosing is calibrated to soften dynamic lines while preserving normal expression, which is a technique question more than a drug question. We cover this in more depth in The Secret to Natural-Looking Results.
Myth 3: “Your Body Builds Immunity and It Stops Working”
Patients sometimes worry that repeat treatments will train their body to resist the toxin. True neutralizing antibody resistance exists, but it’s rare — a case series and literature review in Clinical, Cosmetic and Investigational Dermatology put the global incidence of secondary treatment failure from botulinum toxin type A (seen across Botox, Dysport, and Xeomin) at roughly 0.3% to 6%, and it typically follows years of frequent, high-cumulative-dose treatment rather than a handful of standard cosmetic sessions. If results seem to fade faster than before, it’s far more often about dosing, injection technique, or simply noticing your own face more closely than it is about immunity. Our guide on making Botox last longer covers the factors that are actually in your control.
Myth 4: “Botox Is Only for Wrinkles You Already Have”
Using Botox before lines are fully set — sometimes called “prejuvenation” or, informally, “baby Botox” — has become increasingly common, particularly among younger patients. A 2025 systematic review in the journal Muscles found evidence that early BoNT-A use may reduce muscle hyperactivity and delay the formation of both dynamic and static lines over time, though the authors note that long-term data are still limited. A 2021 survey of U.S. adults recruited online, co-authored by a plastic surgery researcher at the Icahn School of Medicine at Mount Sinai, found that among respondents who had received botulinum toxin injections, 37% said they used it specifically to prevent wrinkles — versus 45% who used it to treat wrinkles they already had. And wrinkle prevention isn’t the only non-corrective use — Botox is also used for excessive sweating and for jaw tension from teeth grinding, which we cover in our hyperhidrosis post and our masseter reduction post.
Myth 5: “All Neurotoxin Brands Are Basically the Same”
Botox, Dysport, Xeomin, and Letybo all work the same general way — by temporarily blocking nerve signals to a targeted muscle — but they’re not interchangeable. They differ in formulation, how quickly they take effect, how far they diffuse from the injection point, and how units are dosed between brands. We break down those differences treatment by treatment in Neurotoxin Showdown: Xeomin vs. Botox vs. Dysport vs. Letybo, and you can see dosing and pricing specifics on our Botox / Dysport treatment page.
Frequently Asked Questions
Is Botox actually FDA-approved for cosmetic use? Yes — onabotulinumtoxinA (Botox Cosmetic) has been FDA-approved for glabellar lines since 2002, with additional approvals since for crow’s feet and forehead lines.
Is there real downtime? No — most patients return to normal activities immediately after treatment. Mild redness or small bumps at injection sites typically resolve within a few hours.
Is counterfeit or mishandled Botox a real risk? Yes, but the risk is tied to unlicensed products and untrained injectors, not to the approved treatment itself — see our coverage of the CDC’s warning on fake and mishandled Botox. Getting treated by a licensed provider using FDA-approved product, as with any HALO treatment, avoids that risk entirely.
How soon will I see results, and how long do they last? Most patients notice visible softening within 3 to 7 days, with full effect by about 2 weeks. Results typically last 3 to 4 months, depending on the area treated and individual factors.